Sofituzumab Biosimilar – Anti-MUC16, CA125 mAb – Research Grade

Reference:
Size

,

Isotype

IgG1, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product nameSofituzumab Biosimilar - Anti-MUC16, CA125 mAb - Research Grade
SourceCAS 1418200-58-4
SpeciesHumanized
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsSofituzumab,DMUC5754A (conjugate),MMUC1206A (nonconjugate),MUC16, CA125,anti-MUC16, CA125
ReferencePX-TA1338
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Sofituzumab Biosimilar - Anti-MUC16, CA125 mAb - Research Grade

General information on Anti-MUC16/CA125[Homo sapiens] (Sofituzumab) Monoclonal Antibody

Sofituzumab is investigated for the treatment of Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Sofituzumab Biosimilar – Anti-MUC16, CA125 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

MUC16 recombinant protein
Antigen

MUC16 recombinant protein

PX-P5181 420€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products